Progenics Pharmaceuticals buy Quitte
Start price
18.09.18
/
50%
€5.40
Target price
18.03.19
€7.22
Performance (%)
-24.21%
End price
18.03.19
€4.10
Summary
This prediction ended on 18.03.19 with a price of €4.10. The price of Progenics Pharmaceuticals has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -24.21%. Quitte has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Progenics Pharmaceuticals | - | - | - | - |
| iShares Core DAX® | -3.986% | -2.814% | 4.157% | 51.377% |
| iShares Nasdaq 100 | 0.345% | -0.748% | 9.471% | 85.925% |
| iShares Nikkei 225® | -3.853% | 4.229% | 28.358% | 56.859% |
| iShares S&P 500 | 0.298% | 0.379% | 6.139% | 59.567% |
Comments by Quitte for this prediction
In the thread Progenics Pharmaceuticals diskutieren
Azedra kommt
https://seekingalpha.com/news/3390597-progenics-adds-azedra-nccn-guidelines-pheochromocytoma-paraganglioma
(Laufzeit überschritten)
Stopped prediction by Quitte for Progenics Pharmaceuticals
Progenics Pharmaceuticals
Start price
Target price
Perf. (%)
€4.05
22.08.19
22.08.19
€5.00
29.06.20
29.06.20
-8.07%
29.06.20
29.06.20
Progenics Pharmaceuticals
Start price
Target price
Perf. (%)
€7.50
16.03.18
16.03.18
€9.47
17.09.18
17.09.18
-32.51%
17.09.18
17.09.18
Progenics Pharmaceuticals
Start price
Target price
Perf. (%)
€3.85
30.01.14
30.01.14
€4.30
25.03.14
25.03.14
-20.86%
25.03.14
25.03.14

